Skip to content

Prediction of REsPonse to Antipsychotics using electRoEncephalography

Prediction of REsPonse to Antipsychotics using electRoEncephalography: Handling Antipsychotic Medication: developing a biomarker to predict medication response

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20422
Enrollment
100
Registered
2020-06-23
Start date
2020-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis

Interventions

None listed

Sponsors

ZonMW
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age between 16 and 40 years old - First psychotic episode, with a classification of schizophrenia, schizophreniform disorder or psychosis not otherwise specified. - Patients need to be antipsychotic medication naïve. Short treatment in the past with antipsychotics is permitted if patients received a dose and duration of the treatment not high enough to expect response. - Patients who are or will be treated with antipsychotics. - Comorbidity is allowed. - The participant needs to understand the study and is able to provide written informed consent. - We will ask patients not to take benzodiazepines 24 hours before the EEG recordings.

Exclusion criteria

Exclusion criteria: - Coercive measures - A history of mental retardation, - Organic brain damage - Organic psychosis. - Patients who are pregnant of patients who are breastfeeding.

Design outcomes

Primary

MeasureTime frame
Remission or response based on PANSS scores

Secondary

MeasureTime frame
Functional well-being, DNA methylation,

Contacts

Public ContactLivia Dominicus

umc Utrecht

l.s.dominicus-2@umcutrecht.nl0613204315

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)